Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Platelet activation, inflammatory mediators and hypercholesterolemia.

Patrizia Ferroni1, Stefania Basili, Giovanni Davi

  • 1Dept. of Experimental Medicine & Pathology, University of Rome, La Sapienza, Italy.

Current Vascular Pharmacology
|August 24, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

CD11c<sup>+</sup> T-Bet<sup>+</sup> B Cell Expansion Reveals a Distinct Pathogenic Signature in Autoimmune Liver Diseases.

Liver international : official journal of the International Association for the Study of the Liver·2026
Same author

Platelet activation and short-term rifaximin therapy in decompensated cirrhosis: a pilot randomized controlled study.

Internal and emergency medicine·2026
Same author

Biomarkers for new-onset atrial fibrillation: between promise and uncertainty.

European journal of preventive cardiology·2026
Same author

Case Report: Extracorporeal photopheresis for cutaneous lupus erythematosus induces putatively atheroprotective B and T cell responses.

Frontiers in immunology·2026
Same author

Reanimation of Stored Tissue Biopsies: A Functional Study and Translational Approach.

International journal of molecular sciences·2026
Same author

A portable system for non-invasive cardiovascular monitoring in older adults: design and validation.

Biomedical physics & engineering express·2026

High cholesterol (hypercholesterolemia) drives inflammation and platelet activation, contributing to atherosclerosis. Understanding this interplay may reveal new therapeutic targets for cardiovascular disease.

Area of Science:

  • Cardiovascular Science
  • Inflammation Research
  • Hematology

Background:

  • Atherosclerosis is linked to altered cholesterol metabolism and inflammation.
  • Inflammatory markers, cytokines, and adhesion molecules are associated with hypercholesterolemia and atherosclerosis.
  • Platelets play a significant role in the inflammatory response within atherosclerotic lesions.

Purpose of the Study:

  • To review the interplay between hypercholesterolemia, inflammation, and platelet activation in atherosclerosis.
  • To explore the pathophysiological implications of platelet activation in atherosclerotic plaque development.
  • To discuss the impact of lipid-lowering treatments on these processes.

Main Methods:

  • Literature review synthesizing current understanding of hypercholesterolemia, inflammation, and platelet function.

Related Experiment Videos

  • Analysis of research on inflammatory mediators released by platelets.
  • Examination of studies on the effects of lipid-lowering therapies.

    • Main Results:

    • Hypercholesterolemia promotes inflammation involving artery wall and circulating cells, notably platelets.
    • Activated platelets synthesize and release pro-inflammatory cytokines and chemokines, contributing to vascular injury.
    • Platelet activation and hemostatic imbalance are implicated in atherosclerotic plaque progression.

    Conclusions:

    • Platelets have a critical, previously unrecognized role in atherosclerosis pathogenesis through inflammatory actions.
    • Targeting platelet activation and inflammation may offer novel therapeutic strategies for atherosclerosis.
    • Lipid-lowering treatments may influence these inflammatory and platelet-related phenomena.